Icon

Tagrisso - (40, 80 mg; Tablet, Oral)

Osimertinib Mesylate Astrazeneca
40, 80 mg; Tablet, Oral
More Than $1000 mn
Less Than 5
Less Than 5
Less Than 5
Less Than 5
None None
TAGRISSO is indicated for the treatment of patients with metastatic epidermal growth factor receptor (EGFR) T790M mutation-positive non-small cell lung cancer
Yes
*** *********** **** ** *** **, **** ***** ******, *******, *** **** *** ****. **** ***** * **** ** ** ****** ******** (*** *, ****) *** **** *********. ** ****** **** **** **** ****** ** ****. ***** (** ** *** ***'*) *** ***** * **** *** ** '*** *** '***. ***** *** ***** **** **** **** *** ********* ** *** **** ******* ** *** ****** **** *** **** ***** * **** *** ** ***** *******.
Tagrisso Patent 1 Patent 2 Patent 3 Patent 4
******* ******* **** *** ******* **** *** ******* *** ********* (***** ******)
*** **** ******* **** *** ******* **** *** ******* *** ********* (***** ******)
***** ****** **** *** **** *** ******* *** ********* (***** ******)
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
******* *** \ ********* *** **, **** ******* ********* ******** ******* *** **** *** *** ****
*** **** *** \ *** *** **, **** ******* ********* ******** ******* *** **** *** *** ****
***** ****** *** \ *** *** **, **** ******* ********* ******** ******* *** **** *** *** ****
  1. *** **, **** : ******* ******** *********** ***** **'* **** ** ****** ** ****** ******** (*** *, ****)
  2. *** *, **** : *** **** ******** *********** ***** **'* **** ** ****** ** ****** ******** (*** *, ****)
  3. *** **, **** : ***** ****** ******** *********** ***** **'* **** ** ****** ** ****** ******** (*** *, ****)
  4. *** **, **** : *********** ***** * **** ******* *******, *** **** *** ***** ****** ** ****** ******** (*** *, ****)
  5. *** **, **** : *********** ******* **** ***** ****** **** ******* *****.
  6. *** **, **** : *********** ******* **** *** ***** ******* *****.
  7. *** **, **** : *********** ******* **** ******* ** ******* *****.

Download ParaIV Report


Download ParaIV Detailed Report


To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.